COMMONWEALTH  OF MASSACHUSETTS

SUFFOLK COUNTY	 				 	BOARD OF REGISTRATION  

 	IN PHARMACY

In the Matter of	)
Karen A. Blakely	) Pharmacist Registration No. 21868	)
 	)

Docket No.  PHA20120004	

CONSENT AGREEMENT

The Board of Registration in Pharmacy ("Board") and Karen A. Blakely, R.Ph. ("Registrant"), a pharmacist registered by the Board (Pharmacist Registration No. 21868), do hereby stipulate and agree that the following information shall be entered into and become a permanent part of the file of the Registrant which is maintained by the Board:

1.	The parties enter into this Consent Agreement ("Agreement") in order to resolve that certain complaint pending against the Registrant as Docket No. PHA20120004 ("Complaint").

2.   The Complaint alleged that on or about July 29, 2011, while employed as a pharmacist at   
      Royal Palm Specialty Pharmacy located at 118 Main Street in Webster, Massachusetts,  
      Registrant failed to properly compound a prescription forT-3 1Omcg SR.

3.   Accordingly, the Registrant freely agrees to the following:

a.	That Registrant's conduct described in Paragraph 2 constitutes professional misconduct warranting disciplinary action by the Board, pursuant to G.L. c. 112,
§§ 42A and 61 and 247 CMR 9.01(1) and 10.03(1), subsections (a) and (k);

b.	Registrant's Massachusetts Pharmacist Registration is hereby REPRIMANDED by the Board for Registrant's conduct in this matter, effective as of the Effective Date of the Agreement;

c.	Within thirty (30) days of the Effective Date of the Agreement, Registrant  shall complete two (2) hours of continuing education related to medication error prevention topics and submit the ORIGINAL certificates of completion to the Board along with a copy of the Agreement;

d.	Within thirty (30) days of the Effective Date of the Agreement, Registrant  shall file a Medication Error Report with the Institute for  Safe Medication Practices (https://www.ismp.org/orderforms /reporterrortoiSMP.asp)  and submit a copy of the report to the Board along with a copy of the Agreement; and   

e.	Registrant shall return a signed copy of the Agreement to the Board within ten
(10) days of receipt.

4.	The Agreement and its contents shall become a part of the records maintained by the Board, and as such, are public records subject to disclosure to the public, other licensing boards, and the National Association of Boards of Pharmacy.

5.     The Board agrees that in return for Registrant's execution of this Agreement, and compliance with
        the terms and conditions set forth in Paragraph 3, the Board will not advance the prosecution of  
        Registrant pursuant to the Complaint; any and all other rights of the Board to take action within   
        the scope of its authority are expressly reserved.

6.     Registrant understands and agrees that the failure to abide by the terms of the Agreement shall   
        nullify the representations contained in Paragraph 5 and permit the Board to initiate formal  
       adjudicatory action under the State Administrative Procedure Act (G.L. c. 30A) and Standard 
       Adjudicatory Rules of Practice and Procedure (801 CMR 1.00 et seq.).

7.    The Registrant understands and agrees that the decision to enter into the Agreement and to accept 
       the terms and conditions herein described is a final act and is not subject to reconsideration or 
       judicial review.

8.    The Registrant states that Registrant has used legal counsel in connection with the decision to enter 
       into this Agreement or, if Registrant did not, that an opportunity to do so was provided and that the
      decision to enter into this Agreement was freely made by Registrant.

9.    Registrant certifies that Registrant has read this document entitled "Consent
       Agreement."

10.   Registrant certifies she has read this document entitled "Consent Agreement" and understands that 
       by executing this Agreement, she is waiving all rights to a  formal hearing at which Registrant 
       would possess the right to confront and cross-examine witnesses, to call witnesses, to present 
       evidence, to personally testify, to contest the allegations, to present oral argument, to appeal in the
       event of an adverse  ruling, and all other rights set forth in the State Administrative Procedure Act 
       (G.L. c. 30A) and the Standard Adjudicatory Rules of Practice and Procedure (801 CMR 1.01 et
       seq.).

							Karen A. Blakely, R. Ph.
     							Date: 8/15/12

							BOARD OF REGISTRATION IN
							PHARMACY

							
							James T. DeVita, R. Ph.
							President 
							Effective Date:  8/30/12
     Decision No. 2969